SW620 and CW-2 cells, which expressed EGFR at the highest and lowest levels, respectively, were used to test the targeting potential of EGFR-Lipo-CPT-11 in EGFR-expressing cancer cells (Fig. 3A and B). The gene discussed is EGFR; the disease is cancer.